Human variation electronic application form (eAF) training session and Q&A clinic, Online, European Medicines Agency, Amsterdam, the Netherlands, from 8 November 2024, 10:00 (CET) to 8 November 2024, 11:00 (CET)

Human variation electronic application form (eAF) training session and Q&A clinic, Online, European Medicines Agency, Amsterdam, the Netherlands, from 8 November 2024, 10:00 (CET) to 8 November 2024, 11:00 (CET)

Q&A clinic Human variations web-based electronic Application Form (eAF) for non-CAPs, Online, European Medicines Agency, Amsterdam, the Netherlands, from 25 October 2024, 10:00 (CEST) to 25 October 2024, 10:30 (CEST)

Q&A clinic Human variations web-based electronic Application Form (eAF) for non-CAPs, Online, European Medicines Agency, Amsterdam, the Netherlands, from 25 October 2024, 10:00 (CEST) to 25 October 2024, 10:30 (CEST)

Human medicines European public assessment report (EPAR): Inaqovi, cedazuridine,decitabine, Date of authorisation: 15/09/2023, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Inaqovi, cedazuridine,decitabine, Date of authorisation: 15/09/2023, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Sutent, sunitinib, Date of authorisation: 19/07/2006, Revision: 41, Status: Authorised

Human medicines European public assessment report (EPAR): Sutent, sunitinib, Date of authorisation: 19/07/2006, Revision: 41, Status: Authorised

Human medicines European public assessment report (EPAR): Silodosin Recordati, silodosin, Date of authorisation: 07/01/2019, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Silodosin Recordati, silodosin, Date of authorisation: 07/01/2019, Revision: 3, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness